nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—Skin candida—Riluzole—amyotrophic lateral sclerosis	0.188	0.191	CcSEcCtD
Cefdinir—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0608	0.0617	CcSEcCtD
Cefdinir—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.0437	0.0443	CcSEcCtD
Cefdinir—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.0431	0.0437	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0413	0.0419	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.0397	0.0403	CcSEcCtD
Cefdinir—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0307	0.0312	CcSEcCtD
Cefdinir—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0307	0.0312	CcSEcCtD
Cefdinir—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0215	CcSEcCtD
Cefdinir—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0207	0.0211	CcSEcCtD
Cefdinir—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0204	0.0207	CcSEcCtD
Cefdinir—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.018	0.0183	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0167	0.017	CcSEcCtD
Cefdinir—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0166	CcSEcCtD
Cefdinir—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0164	CcSEcCtD
Cefdinir—Cefazolin—PON1—amyotrophic lateral sclerosis	0.0146	1	CrCbGaD
Cefdinir—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0144	CcSEcCtD
Cefdinir—Asthma—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0138	CcSEcCtD
Cefdinir—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0131	CcSEcCtD
Cefdinir—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0129	CcSEcCtD
Cefdinir—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0124	CcSEcCtD
Cefdinir—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.012	0.0122	CcSEcCtD
Cefdinir—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0121	CcSEcCtD
Cefdinir—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0118	0.012	CcSEcCtD
Cefdinir—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0118	0.012	CcSEcCtD
Cefdinir—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0118	CcSEcCtD
Cefdinir—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0115	CcSEcCtD
Cefdinir—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.011	0.0111	CcSEcCtD
Cefdinir—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0111	CcSEcCtD
Cefdinir—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0105	CcSEcCtD
Cefdinir—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00936	0.0095	CcSEcCtD
Cefdinir—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00873	0.00886	CcSEcCtD
Cefdinir—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0085	0.00863	CcSEcCtD
Cefdinir—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00835	0.00847	CcSEcCtD
Cefdinir—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00823	0.00835	CcSEcCtD
Cefdinir—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0082	0.00832	CcSEcCtD
Cefdinir—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00809	0.00821	CcSEcCtD
Cefdinir—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00791	0.00803	CcSEcCtD
Cefdinir—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00775	0.00787	CcSEcCtD
Cefdinir—Shock—Riluzole—amyotrophic lateral sclerosis	0.00763	0.00774	CcSEcCtD
Cefdinir—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0077	CcSEcCtD
Cefdinir—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00739	0.0075	CcSEcCtD
Cefdinir—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00711	CcSEcCtD
Cefdinir—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00689	0.00699	CcSEcCtD
Cefdinir—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00682	0.00692	CcSEcCtD
Cefdinir—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00674	0.00684	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00669	0.00679	CcSEcCtD
Cefdinir—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00663	0.00673	CcSEcCtD
Cefdinir—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00634	0.00643	CcSEcCtD
Cefdinir—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00613	0.00622	CcSEcCtD
Cefdinir—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00613	0.00622	CcSEcCtD
Cefdinir—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0058	CcSEcCtD
Cefdinir—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00564	CcSEcCtD
Cefdinir—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00557	CcSEcCtD
Cefdinir—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00538	CcSEcCtD
Cefdinir—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00513	0.0052	CcSEcCtD
Cefdinir—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00493	0.005	CcSEcCtD
Cefdinir—Rash—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00496	CcSEcCtD
Cefdinir—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00496	CcSEcCtD
Cefdinir—Headache—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00493	CcSEcCtD
Cefdinir—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00467	CcSEcCtD
